Vincent Meininger
Overview
Explore the profile of Vincent Meininger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
5678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Canosa A, Calvo A, Mora G, Moglia C, Brunetti M, Barberis M, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979682
: Data from published studies about the effect of HFE polymorphisms on ALS risk, phenotype, and survival are still inconclusive. We aimed at evaluating whether the p.H63D polymorphism is a...
2.
Corcia P, Lejeune P, Vourch P, Beltran S, Piegay A, Blasco H, et al.
Eur J Neurol
. 2022 Sep;
30(2):552-554.
PMID: 36176198
Background: The objective of this study was to characterize the prototypical phenotype of patients with amyotrophic lateral sclerosis (ALS) associated with PFN1 mutations in profilin 1 (PFN1) and to determine...
3.
Teyssou E, Chartier L, Roussel D, Perera N, Nemazanyy I, Langui D, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628504
Mutations in profilin 1 (PFN1) have been identified in rare familial cases of Amyotrophic Lateral Sclerosis (ALS). PFN1 is involved in multiple pathways that could intervene in ALS pathology. However,...
4.
Le Gall L, Duddy W, Martinat C, Mariot V, Connolly O, Milla V, et al.
J Cachexia Sarcopenia Muscle
. 2022 Feb;
13(2):1385-1402.
PMID: 35194965
Background: The cause of the motor neuron (MN) death that drives terminal pathology in amyotrophic lateral sclerosis (ALS) remains unknown, and it is thought that the cellular environment of the...
5.
van Rheenen W, van der Spek R, Bakker M, van Vugt J, Hop P, Zwamborn R, et al.
Nat Genet
. 2022 Feb;
54(3):361.
PMID: 35102318
No abstract available.
6.
van Rheenen W, van der Spek R, Bakker M, van Vugt J, Hop P, Zwamborn R, et al.
Nat Genet
. 2021 Dec;
53(12):1636-1648.
PMID: 34873335
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry genome-wide...
7.
Witzel S, Frauhammer F, Steinacker P, Devos D, Pradat P, Meininger V, et al.
Transl Neurodegener
. 2021 Aug;
10(1):31.
PMID: 34433481
Background: Interventional trials in amyotrophic lateral sclerosis (ALS) suffer from the heterogeneity of the disease as it considerably reduces statistical power. We asked if blood neurofilament light chains (NfL) could...
8.
Muratet F, Teyssou E, Chiot A, Boillee S, Lobsiger C, Bohl D, et al.
J Neurol Neurosurg Psychiatry
. 2021 Mar;
92(9):942-949.
PMID: 33785574
Objective: Mutations in superoxide dismutase 1 gene (, encoding copper/zinc superoxide dismutase protein, are the second most frequent high penetrant genetic cause for amyotrophic lateral sclerosis (ALS) motor neuron disease...
9.
Corcia P, Camu W, Brulard C, Marouillat S, Couratier P, Camdessanche J, et al.
J Neurol Neurosurg Psychiatry
. 2021 Jan;
92(5):479-484.
PMID: 33408239
Objectives: To determine whether the familial clustering of amyotrophic lateral sclerosis (ALS) cases and the phenotype of the disease may help identify the pathogenic genes involved. Methods: We conducted a...
10.
Cardoso S, Meneton P, Aime X, Meininger V, Grabli D, Guezennec G, et al.
PLoS One
. 2021 Jan;
16(1):e0244604.
PMID: 33406098
The objective of this study was to describe the care pathway of patients with amyotrophic lateral sclerosis (ALS) based on real-life textual data from a regional coordination network, the Ile-de-France...